Drug Digest: Engineering LNPs Beyond the Liver for Genetic Medicines

News
Multimedia
Publication
Conferences
Resources
Subscribe
Webcasts
Event Calendar

Spotlight -

Downstream Processing|

Upstream Processing

James Fasano

is scientist at Vector Process Development, ElevateBio.

Articles by James Fasano

David Crockett/Stock.Adobe.com – Rapid growth in cell-based immuno-oncology pipelines and early development efforts with in-vivo lentiviral vector-based therapies are fueling CGT growth.

Tactics and Strategies for Designing an Ideal Lentiviral Vector Platform

ByBojiao Yin,Mercedes Segura Gally,Jimmy Xin,James Fasano

March 1st 2023

There is growing pressure for robust and economically scalable viral-vector manufacturing technologies.

Latest Updated Articles